Live News Reader

Some of the articles presented on this website are accessed through RSS feeds from third-party sources that are not necessarily part of the Histiocytosis Association. While we try to select appropriate feeds to prevent objectionable content from being displayed, the presence of any article does not indicate endorsement or recommendation by the Histiocytosis Association.

If you know of a histio-related article that isn't shown here, please send the article to outreach@histio.org.

"Erdheim-Chester disease" - Google News
Erdheim Chester Disease Treatment Market Is Thriving with Emerging Trends after COVID19 Pandemic – NeighborWebSJ - NeighborWebSJ
Erdheim Chester Disease Treatment Market Is Thriving with Emerging Trends after COVID19 Pandemic – NeighborWebSJ  NeighborWebSJ
Sunday, January 24, 2021 11:45:46 PM

Global Erdheim-Chester Disease Market By Growth, Demand & Opportunities & Forecast To 2027||Hikma Pharmaceuticals PLC, Teva Pharmaceuticals Industries Ltd, Sun Pharmaceuticals Industries Ltd - The Courier
Global Erdheim-Chester Disease Market By Growth, Demand & Opportunities & Forecast To 2027||Hikma Pharmaceuticals PLC, Teva Pharmaceuticals Industries Ltd, Sun Pharmaceuticals Industries Ltd  The Courier
Friday, January 22, 2021 10:10:00 AM

Higher prevalence of hypothyroidism found in patients with Erdheim-Chester disease - Healio
Higher prevalence of hypothyroidism found in patients with Erdheim-Chester disease  Healio
Tuesday, November 17, 2020 3:00:00 AM

UAB joins the Erdheim-Chester Disease Care Center Network - UAB News
UAB joins the Erdheim-Chester Disease Care Center Network  UAB News
Tuesday, February 25, 2020 3:00:00 AM

FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer - FDA.gov
FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer  FDA.gov
Monday, November 6, 2017 3:00:00 AM

FDA Approves Vemurafenib for Treating Erdheim-Chester Disease - Cancer Network
FDA Approves Vemurafenib for Treating Erdheim-Chester Disease  Cancer Network
Wednesday, November 8, 2017 3:00:00 AM

The ultra-rare Erdheim-Chester disease: Turning grief into a campaign for a cure - Washington Post
The ultra-rare Erdheim-Chester disease: Turning grief into a campaign for a cure  Washington Post
Monday, November 17, 2014 3:00:00 AM

Largest Study of Its Kind Reveals New Targetable Genetic Causes of the Rare Blood Disorder Histiocytosis - On Cancer - Memorial Sloan Kettering
Largest Study of Its Kind Reveals New Targetable Genetic Causes of the Rare Blood Disorder Histiocytosis  On Cancer - Memorial Sloan Kettering
Wednesday, December 4, 2019 3:00:00 AM

Top in endocrinology: Hypothyroidism, oral acromegaly capsule - Healio
Top in endocrinology: Hypothyroidism, oral acromegaly capsule  Healio
Wednesday, November 25, 2020 3:00:00 AM

MEK Inhibition Spurs Durable Responses in Patients With Histiocytic Neoplasms - Cancer Therapy Advisor
MEK Inhibition Spurs Durable Responses in Patients With Histiocytic Neoplasms  Cancer Therapy Advisor
Wednesday, March 13, 2019 3:00:00 AM

Share with Others

© Histiocytosis Association, Inc.
332 North Broadway, Pitman, New Jersey  08071 USA
Phone: +1 856-589-6606 | Fax: +1 856-589-6614
| info@histio.org
US & Canada Toll-Free: 1-800-548-2758 
Privacy | DisclaimerState Fundraising Notices 
Tax ID: 22-2827069 | Contact Us 
Instagram   


¿No Habla Inglés? Si usted puede escribirme sus preguntas y preocupaciones a la dirección de correo electrónico: outreach@histio.org. Nosotros podremos responderle tan pronto nos sea possible. Gracias!